microdosing glp 1 for inflammation GLP-1: A New Approach to Inflammation-Driven Diseases | Empowering Midlife Wellness In the Press: New Beauty

therefore, it is too early to predict if GLP-1s will provide benefit for patients with these conditions

Instead, they complement it by giving employees a controlled allowance they can use toward eligible wellness expenses, which may include GLP-1 medications, while keeping spending capped and making benefits easier to administer

Its also FDA-approved under the brand name Victoza to treat type 2 diabetes and to reduce the risk of adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease

Mulvihill and Drucker, 2014)

[DOI] [PubMed] [Google Scholar] 24.Peterson A.C., Russell J.D., Bailey D.J., Westphall M.S., Coon J.J